Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effect of 1 mg tesaglitazar once daily versus placebo once daily given as add?on therapy to metformin on the steady state exposure (AUCss) of metformin in patients with type 2 diabetes with a serum creatinine within normal range and having CrCL>70 mL/min or CrCL≤70 to ≥50mL/min, by assessment after a 12-week randomized treatment period.
Critère d'inclusion
- type II diabetes mellitus